Pentoxifylline in liver ischemia and reperfusion

Journal of Investigative Surgery

Volumn 27, Issue 2, 2014, Pages 114-124

  Genovés, Patricia ^a   García, David ^a   Cejalvo, Dolores ^a   Martin, Antonio ^a   Zaragoza, Cristobal ^b   Toledo, Alexander H ^c   Toledo Pereyra, Luis H ^d   Lloris Carsi, José Miguel ^a,b  

^a UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Hepatic ischemia reperfusion injury; Liver ischemia; Pentoxifylline; Pentoxifylline mechanism; Phosphodiesterase inhibition; TNF inhibition

Indexed keywords

BIOLOGICAL MARKER; NITRIC OXIDE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; PHOSPHODIESTERASE INHIBITOR;

APOPTOSIS; BLOOD RHEOLOGY; CHEMICAL STRUCTURE; DRUG EFFICACY; DRUG MECHANISM; LIVER ISCHEMIA; LIVER PROTECTION; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; HUMAN; ISCHEMIA; LIVER; LIVER DISEASES; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; VASCULARIZATION;

ANIMALS; APOPTOSIS; HUMANS; ISCHEMIA; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896906165     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2013.835454     Document Type: Review

References (64)

1. Drug Information Online [homepage on the Internet]. New Zealand: Drugsite Trust; c2012 [actualized october 10th 2012; cited May 2013]. Available from: http://www.drugs.com/pro/pentoxifylline.html.
2. Marteau P, Ballet F, Chrétien Y, et al. Effect of vasodilators on hepatic microcirculation: a study of the inhibition of Norepinephrine. Induced vasoconstriction on isolated perfused rat liver. Hepatology 1988;8:228-231.
3. Wang P, Ba ZF, Zhou M, et al. Pentoxifylline restores cardiac output and tissue perfusion after traumahemorrhage and decreases susceptibility to sepsis. Surgery 1993;114:352-359. (Pubitemid 23243350)
4. Ellermann J, David H, Lüning M, et al. Effect of pentoxiphylline on the recovery of the preserved rat liver: 31P NMR and ultrastructural studies. NMR Biomed. 1991;4(6):286-293.
5. Bachmann S, Caldwell-Kenkel JC, Currin RT, et al. Ultraestructural correlates of liver graft failure from storage injury: studies of graft protection by Carolina rinse solution and pentoxifylline. Transplant Proc. 1993;25:1620-1624. (Pubitemid 23079126)
6. Astarcioglu H, Karademir S, Unek T, et al. Beneficial effects of pentoxifylline pretreatment in non-heart-beating donors in rats. Transplantation. 2000;69(1):93-98. (Pubitemid 30062614)
7. Fabia R, Travis DL, Levy MF, et al. Effect of pentoxifylline on hepatic ischemia and reperfusion injury. Surgery. 1997;121(5):520-525. (Pubitemid 27202898)
8. Vardareli E, Saricam T, Koken T, et al. The effect of alphatocopherol and pentoxyfilline on ischemia-reperfusion induced liver injury in rats. Hepatogastroenterology. 1998; 45(23):1505-1508. (Pubitemid 28515148)
9. Ernest E. 20 years pentoxifylline: a part of recent angiology history. Wien Med Wochenschr. 1992;142(19):433-437.
10. Porter JM, Cutler BS, Lee BY, et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J. 1982;104(1):66-72. (Pubitemid 13114585)
11. Buhl MR. Purine metabolism in ischemic kidney tissue. p.12. Laegeforeningens, Copenhagen. 1981.
12. Van Waarde A, Stromski M, Thulin G, et al. Protection of kidney against ischemic injury by inhibition of 5′-nucleotidase. 7th Annual meeting of the society of magnetic resonance in medicine. Abstr. 628(1988).
13. Bolling SF, Olszanski DA, Bove EL, et al. Enhanced myocardial protection during global ischemia with 5′-nucleotidase inhibitors. J Thorac Cardiovasc Surg. 1992;103(1):73-77.
14. Hanazawa S, Prewitt RL, Terzis JK. The effect of pentoxifylline on ischemia and reperfusion injury in the rat cremaster muscle. J Reconstr Microsurg. 1994;10(1):21-26. (Pubitemid 24048358)
15. Peng XX, Currin RT, Thurman RG, et al. Protection by pentoxifylline against normothermic liver ischemia/reperfusion in rats. Transplantation. 1995;59(11): 1537-1541.
16. Ratia Giménez T, Navidad Novalvos R, Martínez Onturbe P, et al. Liver damage due to normothermic ischemia and reperfusion in the rat. The effects of pentoxifylline pretreatment. Rev Esp Enferm Dig. 1995;87(7):509-515.
17. Demir S, Inal-Erden M. Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury. Clin Chim Acta. 1998;275(2):127-135. (Pubitemid 28323070)
18. Aslan A, Karagüzel G, Celik M, et al. Pentoxifylline contributes to the hepatic cytoprotective process in rats undergoing hepatic ischemia and reperfusion injury. Eur Surg Res. 2001;33(4):285-290. (Pubitemid 34701889)
19. Romanque P, Uribe M, Videla L. Molecular mechanisms in liver ischemia-reperfusion injury and ischemic preconditioning. Rev Med Chile. 2005; 133: 469-476. (Pubitemid 43126743)
20. Jaesche H. Molecular mechanism of hepatic ischemiareperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284:G15-G26.
21. Idelfonso JA, Arias-Diaz J. Pathophysiology of liver ischemia-reperfusion injury. Cir Esp. 2010;87(4):202-209.
22. Collard CD, Lekowski R, Jordan JE, et al. Complement activation following oxidative stress. Mol Immunol. 1999;36:941-948. (Pubitemid 30100846)
23. Cutrín JC, Perrelli MG, Cavalieri B, et al. Microvascular disfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radical Biol Med. 2002;33:1200-1208. (Pubitemid 35246588)
24. Jaeschke H, Farhood A. Neutrophil and Kupffer cellinduced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol. 1991;260:G355-G362.
25. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365-76. (Pubitemid 19106873)
26. Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury. [Resumen] [86 refs]. J Gastroentero-logy Hepatol. 2000;15:718-24. (Pubitemid 30615053)
27. Lichtman SN, Lemasters JJ. Role of cytokines and cytokineproducing cells in reperfusion injury to the liver. Sem Liver Dis. 1999;19: 171-204.
28. Toledo-Pereyra LH. Organ Preservation for Transplantation. 3rd ed. Austin, TX: Landes Bioscience; 2010.
29. Zhang M, Xu YJ, Mengi SA, et al. Therapeutic potentials of pentoxifylline for the treatment of cardiovascular diseases. Exp Clin Cardiol. 2004;9(2):103-111. (Pubitemid 39173357)
30. Green RM, McNamara J. The effects of pentoxifylline on patients with intermitent claudication. J Vasc Surg. 1988;7:356-362. (Pubitemid 18068693)
31. Badger AM, Olivera DL, Esser KM. Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock. Circ Shock. 1994;44:188.
32. Barton MH, Moore JN. Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia. Circ Shock. 1994;44:216.
33. Ward A, Clissold SP. Pentoxifylline: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs. 1987;34:50.
34. Mollitt DL, Poulos ND. The role of pentoxifylline in endotoxin-induced alterations of red blood cell deformability and whole blood viscosity in the neonate. J Pediatr Surg. 1991;26:572.
35. Müller JM, Brigitte Vollmar, Michael Menger. Pentoxifylline reduces venular leukocyte adherence ("Reflow Paradox") but not microvascular "No Reflow" in hepatic ischemia/reperfusion. J Surg Res. 1997;71:1-6. (Pubitemid 27344028)
36. Colletti LM, Remick DG, Burtch GD, et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest. 1990;85:1936-1943. (Pubitemid 20192970)
37. Cámara-Lemarroy CR, Guzmán de la Garza FJ, Alarcón-Galván G, et al. Effects of thalidomide and pentoxyphylline over local and remote organ injury after intestinal ischemia/reperfusion. Transplant Proc. 2010;42(5):1624-1626.
38. Semmler J, Gebert U, Eisenhut T, et al. Xanthine derivatives: comparison between suppression of tumor necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology 1993;78:520-525. (Pubitemid 23114226)
39. Xiaoyan Zhang, Sharma RK, Ashok A, et al. Effect of pentoxifylline in reducing oxidative stress-induced embryotoxicity. J Assist Reprod Genet. 2005;22:415-417. (Pubitemid 41758744)
40. Trajkovic V, Badovinac V, Popadic D, et al. Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression. Immunology. 1997;92:402-406. (Pubitemid 27488154)
41. Jaeschke H, Bautista AP, Spolarics Z, et al. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun. 1991;15:277-284.
42. Crouch SPM, Fletcher J. Effect of ingested pentoxifylline on neutrophil superoxide anion production. Infect Immun. 1992;60:4504-4509.
43. Meguro M, Katsuramaki T, Nagayama M, et al. A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver. Transplantation. 2002;73:1439-1446. (Pubitemid 34547465)
44. Hsu G-M, Wang J-S, Liu CH, et al. Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock. 2002;17:280-285.
45. Hines IN, Kawachi S, Harada H, et al. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem. 2002;234-235:229-237. (Pubitemid 34777862)
46. Liu P, Xu B, Spokas E, et al. Role of endogenous nitric oxide in TNF-α and IL-1β generation in hepatic ischemiareperfusion. Shock. 2000;13:217-223.
47. Selzner M, Selzner N, Chen L, et al. Exaggerated upregulation of tumor necrosis factor alpha-dependent apoptosis in the older mouse liver following reperfusion injury: targeting liver protective strategies to patient age. Transpl. 2009; 15(11):1594-1604
48. Perry BC, Soltys D, Toledo AH, et al. Tumor necrosis factor-α in liver ischemia/reperfusion injury. J Invest Surg. 2011;24:178-188.
49. Tacke F, Luedde T, Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clinic Rev Allerg Immunol. 2009;36:4-12.
50. Ding W, In X. Dissection of the multiple mechanism of TNF-α-induced apoptosis in liver injury. J Cell Mol Med. 2004;8:445-454. (Pubitemid 44145477)
51. Llacuna L, Marí M, García-Ruiz C, et al. Critical role of acidic sphingomyelinase in murine hepatic ischemiareperfusion injury. Hepatology. 2006;44:561-572. (Pubitemid 44433712)
52. Nishizawa H, Egawa H, Inomata Y, et al. Efficiency of pentoxifylline in donor pretreatment in rat liver transplantation. J Surg Res. 1997;72(2):170-176. (Pubitemid 27495589)
53. Brass CA, Crawford JM, Narciso JP, et al. Evaluation of university ofwisconsin cold-storage solution inwarm hypoxic perfusion of rat liver: the addition of fructose reduces injury. Gastroenterology. 1993;105:1455-1463. (Pubitemid 23315321)
54. Mack VE, Marsh DC, Mack JE, et al. Comparison of cold andwarm ischemic injury in hepatocytes from the rat liver. Transplant Proc. 1993;25:1666-1669. (Pubitemid 23079145)
55. Arnault I, Bao YM, Sebagh M, et al. Beneficial effect of Pentoxifylline on microvesicular steatotic livers submitted to a prolonged cold ischemia. Transplantation. 2003;76(1):77-83. (Pubitemid 36877119)
56. Helling TS, Hacker KA, Kragel PJ, et al. Evidence for cytoprotection by prostaglandin EI with normothermic hepatic ischemia. J Surg Res. 1994;56:309-313. (Pubitemid 24129870)
57. Yildirim S, TokH, köksal H, et al. Allopurinol plus pentoxifilline in hepatic ischaemia/reperfusion injury. Asian J Surg 2002;25(2):149-153. (Pubitemid 34595857)
58. Kaptanoglu L, Kapan M, Kapan S, et al. Effects of nimodipine and pentoxyfylline in prevention of hepatic ischemic damage in rats at normal and hypothermic conditions. Eur J Pharmacol. 2008;587(1-3):253-256.
59. El-Ghoneimi A, Cursio R, Schimd-Alliana A, et al. Pentoxifylline inhibits liver expression of tumor necrosis factor alphamRNA following normothermic ischemia-reperfusion. HPB. 2007;9(2):112-119. (Pubitemid 46672384)
60. Seifi B, Kadkhodaee M, Delavari F, et al. Pretreatment with pentoxifylline and N-acetylcysteine in liverischemia reperfusion-induced renal injury. Ren Fail. 2012;34(5):610-615.
61. Portakal O, Inal-Erden M. Effects of pentoxifylline and coenzyme Q10 in hepatic ischemia/reperfusion injury. Clin Biochem. 1999;32(6):461-466. (Pubitemid 29536179)
62. Qing DK, Dong JH, Han BL, et al. Cold preservation of pig liver grafts with warm ischemia and pentoxifylline-UW solution. Arch Med Res. 2006;37(4):449-455.
63. Mahmoud MF, El Shazly SM, Barakat W. Inhibition of TNF-α protects against hepatic ischemia-reperfusion injury in rats via NF-κB dependent pathway. Naunyn Schmiedebergs Arch Pharmacol. 2012;385(5):465-471.
64. Vician M, Olejnik J, Michalka P, et al. Warm liver ischemia in experiment and lysosomal markers. Bratisl Lek Listy. 2009;110(10):587-591.